Article
Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
Journal of the American Society of Nephrology : JASN - 1 Feb 2018
Lefaucheur Carmen, Viglietti Denis, Hidalgo Luis G, Ratner Lloyd E, Bagnasco Serena M, Batal Ibrahim, Aubert Olivier, Orandi Babak J, Oppenheimer Federico, Bestard Oriol, Rigotti Paolo, Reisaeter Anna V, Kamar Nassim, Lebranchu Yvon, Duong Van Huyen Jean-Paul, Bruneval Patrick, Glotz Denis, Legendre Christophe, Empana Jean-Philippe, Jouven Xavier, Segev Dorry L, Montgomery Robert A, Zeevi Adriana, Halloran Philip F, Loupy Alexandre
Abstract excerpt
Complement-activating anti-HLA donor-specific antibodies (DSAs) are associated with impaired kidney transplant outcome; however, whether these antibodies induce a specific rejection phenotype and influence response to therapy remains undetermined. We prospectively screened 931 kidney recipients for complement-activating DSAs and used histopathology, immunostaining, and allograft gene expression to assess...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
